Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014)

Bio-Techne (TECH) posted quarterly Amortization - Intangibles of $5.7 million for Q3 2014, up 161.79% year-over-year from $2.2 million in Q3 2013, and up 161.79% quarter-over-quarter from $2.2 million in Q3 2013.

Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014) Analysis & Trends

Bio-Techne's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $5.7 million for Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Sep 30, 2014 5.73 Mn
Sep 30, 2013 2.19 Mn
Mar 31, 2011 170,000.00
Dec 31, 2010 171,000.00
Sep 30, 2010 170,000.00
Mar 31, 2010 240,000.00
Dec 31, 2009 240,000.00
Sep 30, 2009 240,000.00